HWKN — Hawkins, Inc. stock price, charts and financials

NASDAQ·Basic Materials·Chemicals - Specialty·USA

Latest market price

133.69

+1.61+1.22%

Overview Short InterestFilings

HWKNQT27Hawkins, Inc.·NASDAQ

Overview Short InterestFilings

133.69+1.22%

Filing

Up 1.2% — Filed an 8-K material-event report (2026-08-03) — details in the filing.

Medium confidence

Loading chart...

Signal & projected range

Falling wedge — reversalHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

CC+4.79%$17.93 NGVT+2.96%$75.58 KWR+3.25%$173.26 WDFC+3.83%$236.00 FUL+3.32%$58.90 ASH+0.79%$72.32 MTX+0.00%$75.21 AVNT+2.09%$38.17

Snapshot

Index	-	P/E	34.63	EPS (ttm)	3.86	Insider Own	5.84%	Shs Outstand	20.88M	Perf Week	-6.52%

Market Cap	2.79B	Forward P/E	28.41	EPS next Y	4.71	Insider Trans	0.25%	Shs Float	19.14M	Perf Month	-4.12%

Enterprise Value	3.04B	PEG	3.03	EPS next Q	1.26	Inst Own	-	Short Float	5.87%	Perf Quarter	-19.00%

Income	80.00M	P/S	2.52	EPS this Y	9.42%	Inst Trans	-	Short Ratio	6.71	Perf Half Y	6.95%

Sales	1.11B	P/B	5.09	EPS next Y	11.43%	ROA	8.01%	Short Interest	1.12M	Perf YTD	-5.89%

Book/sh	26.25	P/C	-	EPS next 5Y	11.43%	ROE	15.30%	52W High	186.15 -28.18%	Perf Year	-15.83%

Cash/sh	0.38	P/FCF	29.15	EPS past 3/5Y	10.99% 15.17%	ROIC	9.53%	52W Low	117.98 13.32%	Perf 3Y	186.58%

Dividend Est.	0.80 (0.60%)	EV/EBITDA	17.48	Sales past 3/5Y	5.05% 12.67%	Gross Margin	22.30%	Volatility	4.70% 3.84%	Perf 5Y	324.14%

Dividend TTM	0.76 (0.57%)	EV/Sales	2.75	EPS Y/Y TTM	-4.22%	Oper. Margin	10.31%	ATR (14)	6.16	Perf 10Y	511.29%

Dividend Ex-Date	Aug 14, 2026	Quick Ratio	1.54	Sales Y/Y TTM	13.55%	Profit Margin	7.29%	RSI (14)	40.18	Recom	2.50

Dividend Gr. 3/5Y	9.74% 9.69%	Current Ratio	2.27	EPS Q/Q	73.08%	SMA20	-3.01%	Beta	0.78	Target Price	142.00

Payout	19.70%	Debt/Eq	0.48	Sales Q/Q	7.85%	SMA50	-9.55%	Rel Volume	1.03	Prev Close	132.08

Employees	1,200	LT Debt/Eq	0.48	Earnings	Nov 04	SMA200	-9.43%	Avg Volume	165.84K	Price	133.69

IPO Date	Mar 18, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.17% 0.72%	Net Debt/EBITDA	1.43	Volume	170,134	Change	1.22%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-31-26	Reiterated	Barclays	Equal Weight	$170 → $142
Jun-30-26	Initiated	Barclays	Equal Weight	$170
Apr-14-25	Upgrade	BWS Financial	Neutral → Buy
Oct-16-24	Downgrade	BWS Financial	Buy → Neutral
Aug-07-23	Upgrade	BWS Financial	Neutral → Buy

Latest News

Jul-29-26

Jul-29-2609:00PM

Hawkins Inc (NASDAQ:HWKN) Q1 Earnings Miss EPS Estimates, Revenue In Line, Stock FlatChartMill

06:26PM

Hawkins (HWKN) Q1 Earnings Lag Estimateszacks.com

04:10PM

Hawkins, Inc. Reports First Quarter Fiscal 2027 Resultsglobenewswire.com

04:05PM

Hawkins, Inc. Increases its Quarterly Cash Dividend by 5% to $0.20 Per Shareglobenewswire.com

Jul-27-26

Jul-27-2603:54AM

Caxton Associates LLP Acquires New Shares in Hawkins, Inc. $HWKNdefenseworld.net

Jul-23-26

Jul-23-2612:41PM

AXTA vs. HWKN: Which Stock Is the Better Value Option?zacks.com

Jul-15-26

Jul-15-2608:30AM

Hawkins, Inc. to Release First Quarter Fiscal 2027 Financial Results on July 29, 2026globenewswire.com

Jun-30-26

Jun-30-2610:00AM

Barclays Initiates Coverage On Hawkins with Equal-Weight Rating, Announces Price Target of $170Benzinga

Jun-25-26

Jun-25-2603:40PM

FUPBY or HWKN: Which Is the Better Value Stock Right Now?Yahoo

Company

Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2026 3/29/2026	FY 2025 3/30/2025	FY 2024 3/31/2024	FY 2023 4/2/2023	FY 2022 4/3/2022	FY 2021 3/28/2021	FY 2020 3/29/2020	FY 2019 3/31/2019
Total Revenue	1,106	1,084	974	919	935	775	597	540	556
Cost of Goods Sold Incl. D&A	860	860	762	726	770	628	473	439	460
Gross Profit	247	224	213	194	165	147	124	101	96
Selling, General and Administrative Excl. Other	132	109	92	90	77	75	68	59	59
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	0	0	0	0	0	0	0	0	0
Operating Income	114	115	121	104	88	71	56	42	37
Interest Expense	7	14	5	4	5	1	1	3	3
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	1	8	-1	1	0	0	1	0	0
Net Income Before Taxes	108	109	114	101	83	70	56	39	34
Income Taxes	26	28	30	26	23	18	15	11	9
Consolidated Net Income	80	82	84	75	60	52	41	28	24
Net Income From Continuing Operations	80	82	84	75	60	52	41	28	24
Net Income	80	82	84	75	60	52	41	28	24
EPS (Recurring)	3.89	3.93	4.05	3.61	2.88	2.46	1.95	1.34	1.15
EPS (Basic, Before Extraordinaries)	3.89	3.93	4.05	3.61	2.88	2.46	1.95	1.34	1.15
EPS (Diluted)	3.86	3.91	4.03	3.59	2.86	2.44	1.93	1.33	1.14
EBITDA	174	175	160	137	117	96	80	63	59
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	34.63	38.91	26.34	21.39	15.31	18.73	17.34	12.51	16.16
Price To Sales Ratio	2.54	2.95	2.29	1.75	0.98	1.24	1.18	0.65	0.70
Gross Margin	22.33	20.66	21.87	21.11	17.65	18.97	20.77	18.70	17.27
Operating Margin	10.31	10.61	12.42	11.32	9.41	9.16	9.38	7.78	6.65
Net Margin	7.23	7.56	8.62	8.16	6.42	6.71	6.87	5.19	4.32
Shares Outstanding	21	21	21	21	21	21	21	21	21
Market Capitalization	2,807	3,195	2,229	1,613	919	960	703	349	387
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Faulconbridge James A	Director	Feb 05 '26	Buy	129.95	1,500	194,925	52,407	Feb 06
Faulconbridge James A	Director	Feb 04 '26	Buy	129.29	1,500	193,935	50,907	Feb 06
Grahek Drew M.	VICE PRESIDENT OF OPERATIONS	Nov 03 '25	Buy	126.34	1,587	200,506	39,640	Nov 05
Faulconbridge James A	Director	Jun 12 '24	Buy	89.94	1,800	161,899	47,817	Jun 14
Faulconbridge James A	Director	Jun 11 '24	Buy	89.05	2,000	178,099	46,017	Jun 12
Faulconbridge James A	Director	Jun 10 '24	Buy	86.47	2,000	172,937	44,017	Jun 12
Faulconbridge James A	Director	Jun 07 '24	Buy	87.53	1,500	131,294	42,017	Jun 10
Faulconbridge James A	Director	Jun 06 '24	Buy	87.56	1,800	157,612	40,517	Jun 10
Faulconbridge James A	Director	Jun 05 '24	Buy	86.57	600	51,942	38,717	Jun 06
Faulconbridge James A	Director	Jun 04 '24	Buy	86.50	1,300	112,454	38,117	Jun 06
Oldenkamp Jeffrey P.	Executive VP and CFO	Feb 11 '22	Buy	39.75	2,300	91,425	69,873	Feb 15
Lange Douglas A.	Vice President - Operations	Aug 21 '20	Buy	49.95	800	39,956	1,159	Aug 26
Moran Theresa R	VP - Purchasing, Logistics	Aug 21 '20	Sale	49.77	3,448	171,607	21,117	Aug 25
Moran Theresa R	VP - Purchasing, Logistics	Aug 13 '20	Sale	59.12	5,266	311,326	24,565	Aug 17
Stauber Daniel J	VP - Health and Nutrition	Nov 06 '18	Buy	37.69	2,000	75,380	7,394	Nov 08

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.